Ellis Christopher
- SEC CIK
- 0001851664
No open-market purchases or sales filed in the past year.
Current role at each company
- BRNS Barinthus Biotherapeutics plc.Chief Operating Officeras of Feb 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ellis Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 (view filing) | Aug 24-25 | 2 days | Ellis ChristopherChief Operating Officer | SSale | −39.6K | $6.55 | −$259.6K | −99.8%75 after | 3 lots |
| Aug 19, 2022 (view filing) | Aug 17-18 | 2 days | Ellis ChristopherChief Operating Officer | SSale | −2.82K | $4.82 | −$13.6K | −97.4%75 after | 2 lots |
| Aug 17, 2022 (view filing) | Aug 15-16 | 2 days | Ellis ChristopherChief Operating Officer | SSale | −7.55K | $4.77 | −$36.0K | −99.0%75 after | 2 lots |
| Jul 15, 2022 (view filing) | Jun 28 | 17 daysLate | Ellis ChristopherChief Operating Officer | SSale | −5 | $6.00 | −$30 | −6.3%75 after |